Acadia Pharmaceuticals (ACAD) Inventory Average (2016 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Inventory Average of $33.1 million for Q1 2026, up 47.55% year-over-year from $22.4 million in Q1 2025, and up 3.88% quarter-over-quarter from $31.9 million in Q4 2025.
Acadia Pharmaceuticals (ACAD) Inventory Average (2016 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Inventory Average history runs 11 years deep, the most recent figure standing at $33.1 million for Q1 2026.
- In Q1 2026, Inventory Average rose 47.55% year-over-year to $33.1 million; the TTM figure through Mar 2026 stood at $33.1 million (up 47.55% YoY), while the FY2025 annual figure was $28.3 million, down 1.99% from the prior year.
- Inventory Average for Q1 2026 stood at $33.1 million, up from $31.9 million in the prior quarter.
- The five-year high for Inventory Average was $66.7 million in Q2 2024, with the low at $6.1 million in Q3 2022.
- The 5-year median for Inventory Average is $24.5 million (2025), against an average of $26.3 million.
- The sharpest annual moves came in 2024 and 2025: Inventory Average soared 772.64% in 2024, then sank 63.23% in 2025.
- Acadia Pharmaceuticals' Inventory Average stood at $6.2 million in 2022, then surged by 353.42% to $28.3 million in 2023, then surged by 46.66% to $41.5 million in 2024, then retreated by 23.16% to $31.9 million in 2025, then climbed by 3.88% to $33.1 million in 2026.
- Business Quant data shows ACAD's Inventory Average at $33.1 million in Q1 2026, $31.9 million in Q4 2025, and $27.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | 31.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.97 Mn |
| Mar 31, 2026 | 33.12 Mn |
| Dec 31, 2025 | 31.88 Mn |
| Sep 30, 2025 | 27.61 Mn |
| Jun 30, 2025 | 24.54 Mn |
| Mar 31, 2025 | 22.45 Mn |
| Dec 31, 2024 | 41.50 Mn |
| Sep 30, 2024 | 66.28 Mn |
| Jun 30, 2024 | 66.73 Mn |
| Mar 31, 2024 | 48.88 Mn |
| Dec 31, 2023 | 28.29 Mn |
| Sep 30, 2023 | 14.98 Mn |
| Jun 30, 2023 | 7.65 Mn |
| Mar 31, 2023 | 6.37 Mn |
| Dec 31, 2022 | 6.24 Mn |
| Sep 30, 2022 | 6.09 Mn |
| Jun 30, 2022 | 6.67 Mn |
| Mar 31, 2022 | 7.45 Mn |
| Dec 31, 2021 | 11.11 Mn |
| Sep 30, 2021 | 12.56 Mn |